Voyageur Pharmaceuticals Ltd. reported earnings results for the second quarter and six months ended May 31, 2022. For the second quarter, the company reported net loss was CAD 0.476512 million compared to CAD 0.327207 million a year ago.
For the six months, net loss was CAD 0.751486 million compared to CAD 0.412218 million a year ago. Basic loss per share from continuing operations was CAD 0.01.